Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

Authors: Vázquez‐Costa, Juan F., Borrego‐Hernández, Daniel, Paradas, Carmen, Gómez‐Caravaca, María Teresa, Rojas‐Garcia, Ricardo, Varona, Luis, Povedano, Mónica, García‐Sobrino, Tania, Jericó Pascual, Ivonne, Gutiérrez, Antonio, Riancho, Javier, Turon‐Sans, Janina, Assialioui, Abdelilah, Pérez‐Tur, Jordi, Sevilla, Teresa, Esteban Pérez, Jesús, García‐Redondo, Alberto, López, Alberto Andrés, Calabria, M. Dolores, Díaz‐Marín, Carmen, Caravaca, Eva Fages, Dávila, Lucía Galán, Martínez, Alberto García, Gimenez‐Muñoz, Álvaro, Sola, Antonio Guerrero, Cadavid, Javier Mascías, Mora Pardina, Jesús S., Blanco, José Luis Muñoz, Juntas‐Morales, Raúl, Morgado, Yolanda, Pardo, Julio, Valladares, Amador, Vilar‐Ventura, Rosa Maria

Source: European journal of neurology. 30(4):861-871

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182000623.0x000001&indx=1&recIds=ETOCvdc_100182000623.0x000001

Erenumab for the treatment of chronic resistant migraine

Alternate Title: Erenumab para el tratamiento de migraña crónica farmacorresistente (Spanish; Castilian)

Authors: Layos-Romero, Almudena ^*, López, Alberto Andrés, Rojas Bartolomé, Laura

Source: In Medicina Clínica (English Edition) 21 January 2022 158(2):96-97